fibronostics-facebook fibronostics-linkedin fibronostics-twitter fibronostics-shape-icon

PRODUCTS

An array of non-invasive solutions for diagnosis, screening and monitoring
LIVERFASt™ is a blood based diagnostic test that combines 10 biomarkers and algorithm technology to determine the fibrosis, activity and steatosis stages of the liver.

Biomarkers

  • Alpha-2-Macroglobulin
  • Haptoglobin
  • Apolipoprotein A1
  • Total Bilirubin
  • GGT
  • ALT (P5P)
  • AST (P5P)
  • Fasting Glucose
  • Triglyceride
  • Total Cholesterol
LIVERFACt is a component of LIVERFASt™ that utilizes only 6 out of the 10 biomarkers to provide results for fibrosis and activity stages of the liver. LIVERFACt enables early diagnosis of liver disease in patients with Hepatitis B and Hepatitis C.

Biomarkers

  • Alpha-2-Macroglobulin
  • Haptoglobin
  • Apolipoprotein A1
  • Total Bilirubin
  • GGT
  • ALT (P5P)
SteatoTEST applies the similar 10 biomarkers that LIVERFASt™ utilizes and provides results for the staging of liver steatosis or also known as fatty liver.

Biomarkers

  • Alpha-2-Macroglobulin
  • Haptoglobin
  • Apolipoprotein A1
  • Total Bilirubin
  • GGT
  • ALT (P5P)
  • AST (P5P)
  • Fasting Glucose
  • Triglyceride
  • Total Cholesterol
LIVERFASt select is a risk stratification tool for fatty liver disease that utilizes a combination of basic blood biomarkers and algorithm technology.

Biomarkers

  • Total Bilirubin
  • GGT
  • ALT (P5P)
  • Fasting Glucose
  • Triglyceride
  • Total Cholesterol
HealthFACTR employs technology to predict risk – providing results for risks of coronary heart disease, stroke, diabetes and fatty liver disease.

Biomarkers

  • LDL Cholesterol
  • HDL Cholesterol
  • Body Fat Percentage
  • Triglyceride
  • Total Cholesterol
HealthFACTR Fibronostics
*
*
Fibronostics logo
*
*